Benzinga's Top Upgrades, Downgrades For October 28, 2020

Benzinga的顶级升级，2020年10月28日的降级

Benzinga Real-time News · 2020/10/28 12:38

Upgrades

For Omnicom Group Inc (NYSE:OMC), MoffettNathanson upgraded the previous rating of Sell to the current rating Neutral. Omnicom Group earned $1.21 in the third quarter, compared to $1.32 in the year-ago quarter. At the moment, the stock has a 52-week-high of 82.73 and a 52-week-low of 46.37. Omnicom Group closed at $48.81 at the end of the last trading period.
For Advanced Micro Devices Inc (NASDAQ:AMD), Craig-Hallum upgraded the previous rating of Hold to the current rating Buy. For the third quarter, Advanced Micro Devices had an EPS of $0.41, compared to year-ago quarter EPS of $0.18. At the moment, the stock has a 52-week-high of 94.28 and a 52-week-low of 31.83. Advanced Micro Devices closed at $78.88 at the end of the last trading period.
B. Riley FBR upgraded the previous rating for ViewRay Inc (NASDAQ:VRAY) from Neutral to Buy. For the second quarter, ViewRay had an EPS of $0.18, compared to year-ago quarter EPS of $0.32. The current stock performance of ViewRay shows a 52-week-high of 4.88 and a 52-week-low of 1.1055. Moreover, at the end of the last trading period, the closing price was at $3.00.
Deutsche Bank upgraded the previous rating for Lululemon Athletica Inc (NASDAQ:LULU) from Hold to Buy. For the second quarter, Lululemon Athletica had an EPS of $0.74, compared to year-ago quarter EPS of $0.96. The stock has a 52-week-high of 399.8965 and a 52-week-low of 128.845. At the end of the last trading period, Lululemon Athletica closed at $333.81.
According to JP Morgan, the prior rating for Xilinx Inc (NASDAQ:XLNX) was changed from Underweight to Neutral. Xilinx earned $0.79 in the second quarter, compared to $0.94 in the year-ago quarter. The stock has a 52-week-high of 130.4 and a 52-week-low of 67.68. At the end of the last trading period, Xilinx closed at $124.35.
JP Morgan upgraded the previous rating for Sherwin-Williams Co (NYSE:SHW) from Neutral to Overweight. In the third quarter, Sherwin-Williams showed an EPS of $8.29, compared to $6.65 from the year-ago quarter. The current stock performance of Sherwin-Williams shows a 52-week-high of 725.91 and a 52-week-low of 325.43. Moreover, at the end of the last trading period, the closing price was at $673.04.
For MSC Industrial Direct Co Inc (NYSE:MSM), Raymond James upgraded the previous rating of Underperform to the current rating Market Perform. In the fourth quarter, MSC Industrial Direct Co showed an EPS of $1.09, compared to $1.30 from the year-ago quarter. At the moment, the stock has a 52-week-high of 79.87 and a 52-week-low of 44.93. MSC Industrial Direct Co closed at $67.72 at the end of the last trading period.
Barclays upgraded the previous rating for First Solar Inc (NASDAQ:FSLR) from Underweight to Equal-Weight. First Solar earned $1.45 in the third quarter, compared to $0.29 in the year-ago quarter. The stock has a 52-week-high of 87.44 and a 52-week-low of 28.47. At the end of the last trading period, First Solar closed at $82.39.
For Advanced Micro Devices Inc (NASDAQ:AMD), Barclays upgraded the previous rating of Equal-Weight to the current rating Overweight. For the third quarter, Advanced Micro Devices had an EPS of $0.41, compared to year-ago quarter EPS of $0.18. The current stock performance of Advanced Micro Devices shows a 52-week-high of 94.28 and a 52-week-low of 31.83. Moreover, at the end of the last trading period, the closing price was at $78.88.
According to Keefe, Bruyette & Woods, the prior rating for Invesco Ltd (NYSE:IVZ) was changed from Market Perform to Outperform. For the third quarter, Invesco had an EPS of $0.53, compared to year-ago quarter EPS of $0.70. The stock has a 52-week-high of 19.01 and a 52-week-low of 6.375. At the end of the last trading period, Invesco closed at $13.96.

Downgrades

According to Craig-Hallum, the prior rating for Enphase Energy Inc (NASDAQ:ENPH) was changed from Buy to Hold. For the third quarter, Enphase Energy had an EPS of $0.30, compared to year-ago quarter EPS of $0.30. The stock has a 52-week-high of 118.939 and a 52-week-low of 17.18. At the end of the last trading period, Enphase Energy closed at $98.63.
For Enphase Energy Inc (NASDAQ:ENPH), HC Wainwright & Co. downgraded the previous rating of Buy to the current rating Neutral. For the third quarter, Enphase Energy had an EPS of $0.30, compared to year-ago quarter EPS of $0.30. The current stock performance of Enphase Energy shows a 52-week-high of 118.939 and a 52-week-low of 17.18. Moreover, at the end of the last trading period, the closing price was at $98.63.
According to Goldman Sachs, the prior rating for Relmada Therapeutics Inc (NASDAQ:RLMD) was changed from Buy to Neutral. At the moment, the stock has a 52-week-high of 54.0 and a 52-week-low of 21.85. Relmada Therapeutics closed at $33.06 at the end of the last trading period.
For Exact Sciences Corp (NASDAQ:EXAS), Citigroup downgraded the previous rating of Buy to the current rating Neutral. In the third quarter, Exact Sciences showed an EPS of $0.07, compared to $0.31 from the year-ago quarter. The current stock performance of Exact Sciences shows a 52-week-high of 141.9 and a 52-week-low of 35.2512. Moreover, at the end of the last trading period, the closing price was at $131.12.
For Everbridge Inc (NASDAQ:EVBG), B of A Securities downgraded the previous rating of Buy to the current rating Neutral. In the second quarter, Everbridge showed an EPS of $0.06, compared to $0.07 from the year-ago quarter. The current stock performance of Everbridge shows a 52-week-high of 165.79 and a 52-week-low of 66.19. Moreover, at the end of the last trading period, the closing price was at $128.68.
For Armstrong World Industries Inc (NYSE:AWI), B of A Securities downgraded the previous rating of Buy to the current rating Neutral. The stock has a 52-week-high of 111.46 and a 52-week-low of 61.56. At the end of the last trading period, Armstrong World Indus closed at $62.91.
According to Stifel, the prior rating for New Fortress Energy Inc (NASDAQ:NFE) was changed from Buy to Hold. New Fortress Energy earned $0.24 in the second quarter, compared to $0.28 in the year-ago quarter. At the moment, the stock has a 52-week-high of 54.92 and a 52-week-low of 7.01. New Fortress Energy closed at $49.16 at the end of the last trading period.
According to Morgan Stanley, the prior rating for Harley-Davidson Inc (NYSE:HOG) was changed from Overweight to Equal-Weight. The stock has a 52-week-high of 40.86 and a 52-week-low of 14.31. At the end of the last trading period, Harley-Davidson closed at $35.37.
Evercore ISI Group downgraded the previous rating for Frontline Ltd (NYSE:FRO) from In-Line to Underperform. Frontline earned $1.04 in the second quarter, compared to $0.02 in the year-ago quarter. At the moment, the stock has a 52-week-high of 13.33 and a 52-week-low of 5.98. Frontline closed at $6.04 at the end of the last trading period.
According to JP Morgan, the prior rating for FB Financial Corp (NYSE:FBK) was changed from Neutral to Underweight. In the third quarter, FB Financial earned $1.46. At the moment, the stock has a 52-week-high of 40.33 and a 52-week-low of 14.38. FB Financial closed at $28.65 at the end of the last trading period.
Barclays downgraded the previous rating for Diamondback Energy Inc (NASDAQ:FANG) from Overweight to Equal-Weight. Diamondback Energy earned $0.15 in the second quarter, compared to $2.11 in the year-ago quarter. The stock has a 52-week-high of 96.92 and a 52-week-low of 14.55. At the end of the last trading period, Diamondback Energy closed at $26.57.
For DTE Energy Co (NYSE:DTE), BMO Capital downgraded the previous rating of Outperform to the current rating Market Perform. In the third quarter, DTE Energy showed an EPS of $2.61, compared to $1.91 from the year-ago quarter. At the moment, the stock has a 52-week-high of 135.67 and a 52-week-low of 71.21. DTE Energy closed at $127.25 at the end of the last trading period.
According to Credit Suisse, the prior rating for Veoneer Inc (NYSE:VNE) was changed from Neutral to Underperform. In the third quarter, Veoneer showed an EPS of $0.96, compared to $1.20 from the year-ago quarter. The stock has a 52-week-high of 18.9 and a 52-week-low of 5.25. At the end of the last trading period, Veoneer closed at $15.83.
For Varian Medical Systems Inc (NYSE:VAR), Baird downgraded the previous rating of Outperform to the current rating Neutral. For the fourth quarter, Varian Medical Systems had an EPS of $1.12, compared to year-ago quarter EPS of $1.21. The stock has a 52-week-high of 176.19 and a 52-week-low of 89.62. At the end of the last trading period, Varian Medical Systems closed at $173.02.
According to Piper Sandler, the prior rating for Livongo Health Inc (NASDAQ:LVGO) was changed from Overweight to Neutral. For the third quarter, Livongo Health had an EPS of No EPS Value , compared to year-ago quarter EPS of $0.05. At the moment, the stock has a 52-week-high of 151.049 and a 52-week-low of 18.76. Livongo Health closed at $142.89 at the end of the last trading period.

Initiations

UBS initiated coverage on Vertex Pharmaceuticals Inc (NASDAQ:VRTX) with a Buy rating. The price target for Vertex Pharmaceuticals is set to $287.00. Vertex Pharmaceuticals earned $2.61 in the second quarter, compared to $1.26 in the year-ago quarter. At the moment, the stock has a 52-week-high of 306.08 and a 52-week-low of 192.32. Vertex Pharmaceuticals closed at $212.19 at the end of the last trading period.
With a current rating of Buy, Berenberg initiated coverage on Terreno Realty Corp (NYSE:TRNO). The price target seems to have been set at $70.00 for Terreno Realty. Terreno Realty earned $0.19 in the second quarter, compared to $0.33 in the year-ago quarter. At the moment, the stock has a 52-week-high of 64.24 and a 52-week-low of 42.115. Terreno Realty closed at $58.25 at the end of the last trading period.
UBS initiated coverage on Sarepta Therapeutics Inc (NASDAQ:SRPT) with a Buy rating. The price target for Sarepta Therapeutics is set to $212.00. For the second quarter, Sarepta Therapeutics had an EPS of $1.51, compared to year-ago quarter EPS of $0.83. At the moment, the stock has a 52-week-high of 175.0 and a 52-week-low of 78.06. Sarepta Therapeutics closed at $139.62 at the end of the last trading period.
Berenberg initiated coverage on Rexford Industrial Realty Inc (NYSE:REXR) with a Buy rating. The price target for Rexford Industrial Realty is set to $56.00. For the third quarter, Rexford Industrial Realty had an EPS of $0.33, compared to year-ago quarter EPS of $0.31. At the moment, the stock has a 52-week-high of 53.48 and a 52-week-low of 31.7871. Rexford Industrial Realty closed at $47.69 at the end of the last trading period.
With a current rating of Buy, Berenberg initiated coverage on Plymouth Industrial REIT Inc (NYSE:PLYM). The price target seems to have been set at $15.00 for Plymouth Industrial REIT. Plymouth Industrial REIT earned $0.45 in the second quarter, compared to $0.43 in the year-ago quarter. At the moment, the stock has a 52-week-high of 21.4964 and a 52-week-low of 7.79. Plymouth Industrial REIT closed at $12.75 at the end of the last trading period.
UBS initiated coverage on PTC Therapeutics Inc (NASDAQ:PTCT) with a Neutral rating. The price target for PTC Therapeutics is set to $55.00. PTC Therapeutics earned $2.62 in the second quarter, compared to $0.75 in the year-ago quarter. The current stock performance of PTC Therapeutics shows a 52-week-high of 59.89 and a 52-week-low of 30.7923. Moreover, at the end of the last trading period, the closing price was at $53.26.
Berenberg initiated coverage on Monmouth Real Estate Investment Corp (NYSE:MNR) with a Buy rating. The price target for Monmouth Real Estate Inv is set to $17.00. For the third quarter, Monmouth Real Estate Inv had an EPS of $0.20, compared to year-ago quarter EPS of $0.21. The stock has a 52-week-high of 15.53 and a 52-week-low of 8.42. At the end of the last trading period, Monmouth Real Estate Inv closed at $14.22.
With a current rating of Buy, UBS initiated coverage on Immunovant Inc (NASDAQ:IMVT). The price target seems to have been set at $61.00 for Immunovant. Immunovant earned $0.38 in the first quarter. The current stock performance of Immunovant shows a 52-week-high of 43.9399 and a 52-week-low of 8.34. Moreover, at the end of the last trading period, the closing price was at $42.93.
With a current rating of Neutral, UBS initiated coverage on Gilead Sciences Inc (NASDAQ:GILD). The price target seems to have been set at $61.00 for Gilead Sciences. Gilead Sciences earned No EPS Value in the third quarter, compared to $1.75 in the year-ago quarter. The current stock performance of Gilead Sciences shows a 52-week-high of 85.97 and a 52-week-low of 59.395. Moreover, at the end of the last trading period, the closing price was at $60.01.
With a current rating of Buy, B of A Securities initiated coverage on Cal-Maine Foods Inc (NASDAQ:CALM). The price target seems to have been set at $47.00 for Cal-Maine Foods. In the first quarter, Cal-Maine Foods showed an EPS of $0.40, compared to $0.94 from the year-ago quarter. At the moment, the stock has a 52-week-high of 46.6576 and a 52-week-low of 30.74. Cal-Maine Foods closed at $38.87 at the end of the last trading period.
With a current rating of Neutral, UBS initiated coverage on Biogen Inc (NASDAQ:BIIB). The price target seems to have been set at $268.00 for Biogen. Biogen earned $8.84 in the third quarter, compared to $9.17 in the year-ago quarter. The current stock performance of Biogen shows a 52-week-high of 374.99 and a 52-week-low of 254.925. Moreover, at the end of the last trading period, the closing price was at $255.30.
With a current rating of Neutral, UBS initiated coverage on Amgen Inc (NASDAQ:AMGN). The price target seems to have been set at $232.00 for Amgen. Amgen earned No EPS Value in the third quarter, compared to $3.66 in the year-ago quarter. The stock has a 52-week-high of 264.97 and a 52-week-low of 177.05. At the end of the last trading period, Amgen closed at $223.46.
With a current rating of Neutral, UBS initiated coverage on Alexion Pharmaceuticals Inc (NASDAQ:ALXN). The price target seems to have been set at $133.00 for Alexion Pharmaceuticals. In the second quarter, Alexion Pharmaceuticals showed an EPS of $3.11, compared to $2.64 from the year-ago quarter. The current stock performance of Alexion Pharmaceuticals shows a 52-week-high of 128.57 and a 52-week-low of 72.67. Moreover, at the end of the last trading period, the closing price was at $120.00.
With a current rating of Neutral, JP Morgan initiated coverage on Hyliion Holdings Corp (NYSE:HYLN). The price target seems to have been set at $27.00 for Hyliion Holdings. The stock has a 52-week-high of 44.9 and a 52-week-low of 20.4. At the end of the last trading period, Hyliion Holdings closed at $21.31.
Jefferies initiated coverage on Burlington Stores Inc (NYSE:BURL) with a Buy rating. The price target for Burlington Stores is set to $255.00. In the second quarter, Burlington Stores showed an EPS of $0.56, compared to $1.36 from the year-ago quarter. The stock has a 52-week-high of 250.89 and a 52-week-low of 105.67. At the end of the last trading period, Burlington Stores closed at $200.18.

Upgrades

升级

For Omnicom Group Inc (NYSE:OMC), MoffettNathanson upgraded the previous rating of Sell to the current rating Neutral. Omnicom Group earned $1.21 in the third quarter, compared to $1.32 in the year-ago quarter. At the moment, the stock has a 52-week-high of 82.73 and a 52-week-low of 46.37. Omnicom Group closed at $48.81 at the end of the last trading period.
For Advanced Micro Devices Inc (NASDAQ:AMD), Craig-Hallum upgraded the previous rating of Hold to the current rating Buy. For the third quarter, Advanced Micro Devices had an EPS of $0.41, compared to year-ago quarter EPS of $0.18. At the moment, the stock has a 52-week-high of 94.28 and a 52-week-low of 31.83. Advanced Micro Devices closed at $78.88 at the end of the last trading period.
B. Riley FBR upgraded the previous rating for ViewRay Inc (NASDAQ:VRAY) from Neutral to Buy. For the second quarter, ViewRay had an EPS of $0.18, compared to year-ago quarter EPS of $0.32. The current stock performance of ViewRay shows a 52-week-high of 4.88 and a 52-week-low of 1.1055. Moreover, at the end of the last trading period, the closing price was at $3.00.
Deutsche Bank upgraded the previous rating for Lululemon Athletica Inc (NASDAQ:LULU) from Hold to Buy. For the second quarter, Lululemon Athletica had an EPS of $0.74, compared to year-ago quarter EPS of $0.96. The stock has a 52-week-high of 399.8965 and a 52-week-low of 128.845. At the end of the last trading period, Lululemon Athletica closed at $333.81.
According to JP Morgan, the prior rating for Xilinx Inc (NASDAQ:XLNX) was changed from Underweight to Neutral. Xilinx earned $0.79 in the second quarter, compared to $0.94 in the year-ago quarter. The stock has a 52-week-high of 130.4 and a 52-week-low of 67.68. At the end of the last trading period, Xilinx closed at $124.35.
JP Morgan upgraded the previous rating for Sherwin-Williams Co (NYSE:SHW) from Neutral to Overweight. In the third quarter, Sherwin-Williams showed an EPS of $8.29, compared to $6.65 from the year-ago quarter. The current stock performance of Sherwin-Williams shows a 52-week-high of 725.91 and a 52-week-low of 325.43. Moreover, at the end of the last trading period, the closing price was at $673.04.
For MSC Industrial Direct Co Inc (NYSE:MSM), Raymond James upgraded the previous rating of Underperform to the current rating Market Perform. In the fourth quarter, MSC Industrial Direct Co showed an EPS of $1.09, compared to $1.30 from the year-ago quarter. At the moment, the stock has a 52-week-high of 79.87 and a 52-week-low of 44.93. MSC Industrial Direct Co closed at $67.72 at the end of the last trading period.
Barclays upgraded the previous rating for First Solar Inc (NASDAQ:FSLR) from Underweight to Equal-Weight. First Solar earned $1.45 in the third quarter, compared to $0.29 in the year-ago quarter. The stock has a 52-week-high of 87.44 and a 52-week-low of 28.47. At the end of the last trading period, First Solar closed at $82.39.
For Advanced Micro Devices Inc (NASDAQ:AMD), Barclays upgraded the previous rating of Equal-Weight to the current rating Overweight. For the third quarter, Advanced Micro Devices had an EPS of $0.41, compared to year-ago quarter EPS of $0.18. The current stock performance of Advanced Micro Devices shows a 52-week-high of 94.28 and a 52-week-low of 31.83. Moreover, at the end of the last trading period, the closing price was at $78.88.
According to Keefe, Bruyette & Woods, the prior rating for Invesco Ltd (NYSE:IVZ) was changed from Market Perform to Outperform. For the third quarter, Invesco had an EPS of $0.53, compared to year-ago quarter EPS of $0.70. The stock has a 52-week-high of 19.01 and a 52-week-low of 6.375. At the end of the last trading period, Invesco closed at $13.96.

为宏盟集团(Omnicom Group Inc.)纽约证券交易所代码：OMC)，MoffettNathanson将之前的评级上调为卖出，目前评级为中性。宏盟集团第三季度盈利1.21美元，而去年同期为1.32美元。目前，该股的52周高点为82.73，52周低点为46.37。宏盟集团上交易期尾盘收报48.81美元。
为先进微设备公司(纳斯达克：AMD)，Craig-Hallum将之前的评级为持有上调至当前评级买入。第三季度，Advanced Micro Devices的每股收益为0.41美元，而去年同期为0.18美元。目前，该股的52周高点为94.28，52周低点为31.83。Advanced Micro Devices上一交易期尾盘收报78.88美元。
B.Riley FBR上调了之前的评级ViewRay Inc.(纳斯达克：弗雷)从中性到买入。第二季度，ViewRay的每股收益为0.18美元，而去年同期为0.32美元。目前ViewRay的股票表现显示，52周高点为4.88%，52周低点为1.1055。而且，在上个交易期结束时，收盘价为3.00美元。
德意志银行上调之前的评级为露露柠檬运动公司(纳斯达克：露露)从持有到买入。第二季度，露露柠檬运动公司的每股收益为0.74美元，而去年同期为0.96美元。该股的52周高点为399.8965，52周低点为128.845。上交易期尾盘，露露柠檬竞技股收报333.81美元。
根据摩根大通(JP Morgan)的说法，之前的评级为Xilinx Inc.(纳斯达克：XLNX)从减持改为中性。Xilinx第二季度的利润为0.79美元，而去年同期为0.94美元。该股的52周高点为130.4，52周低点为67.68.上交易期尾盘，Xilinx收报124.35美元。
摩根大通上调了之前的评级，舍温-威廉姆斯公司纽约证券交易所代码：Shw)从中性到超重。舍温-威廉姆斯第三季度每股收益为8.29美元，而去年同期为6.65美元。舍温-威廉姆斯目前的股票表现显示，52周高点为725.91，52周低点为325.43。而且，在上个交易期结束时，收盘价为673.04美元。
为MSC工业直接公司纽约证券交易所代码：男男性接触者)，Raymond James将之前对UnderPerformance的评级上调至当前评级市场表现。MSC Industrial Direct Co第四季EPS为1.09美元，上年同期为1.30美元.目前，该股的52周高点为79.87，52周低点为44.93。MSC Industrial Direct Co上一交易期尾盘收报67.72美元。
巴克莱上调了之前的评级为第一太阳能公司(纳斯达克：FSLR从体重不足到体重相等。First Solar第三季度盈利1.45美元，而去年同期为0.29美元。该股的52周高点为87.44，52周低点为28.47。上交易期尾盘，First Solar收报82.39美元。
为先进微设备公司(纳斯达克：AMD)，巴克莱将之前的评级上调为等权重至当前评级加码。第三季度，Advanced Micro Devices的每股收益为0.41美元，而去年同期为0.18美元。目前Advanced Micro Devices的股票表现显示52周高点为94.28，52周低点为31.83。而且，在上个交易期结束时，收盘价为78.88美元。
根据Keefe，Bruyette&Woods的说法，之前的评级为景顺有限公司纽约证券交易所代码：IVZ)从市场表现改为跑赢大盘。第三季度，景顺的每股收益为0.53美元，而去年同期为0.70美元。该股的52周高点为19.01点，52周低点为6.375点。上一交易期尾盘，景顺收报13.96美元。

Downgrades

降级

According to Craig-Hallum, the prior rating for Enphase Energy Inc (NASDAQ:ENPH) was changed from Buy to Hold. For the third quarter, Enphase Energy had an EPS of $0.30, compared to year-ago quarter EPS of $0.30. The stock has a 52-week-high of 118.939 and a 52-week-low of 17.18. At the end of the last trading period, Enphase Energy closed at $98.63.
For Enphase Energy Inc (NASDAQ:ENPH), HC Wainwright & Co. downgraded the previous rating of Buy to the current rating Neutral. For the third quarter, Enphase Energy had an EPS of $0.30, compared to year-ago quarter EPS of $0.30. The current stock performance of Enphase Energy shows a 52-week-high of 118.939 and a 52-week-low of 17.18. Moreover, at the end of the last trading period, the closing price was at $98.63.
According to Goldman Sachs, the prior rating for Relmada Therapeutics Inc (NASDAQ:RLMD) was changed from Buy to Neutral. At the moment, the stock has a 52-week-high of 54.0 and a 52-week-low of 21.85. Relmada Therapeutics closed at $33.06 at the end of the last trading period.
For Exact Sciences Corp (NASDAQ:EXAS), Citigroup downgraded the previous rating of Buy to the current rating Neutral. In the third quarter, Exact Sciences showed an EPS of $0.07, compared to $0.31 from the year-ago quarter. The current stock performance of Exact Sciences shows a 52-week-high of 141.9 and a 52-week-low of 35.2512. Moreover, at the end of the last trading period, the closing price was at $131.12.
For Everbridge Inc (NASDAQ:EVBG), B of A Securities downgraded the previous rating of Buy to the current rating Neutral. In the second quarter, Everbridge showed an EPS of $0.06, compared to $0.07 from the year-ago quarter. The current stock performance of Everbridge shows a 52-week-high of 165.79 and a 52-week-low of 66.19. Moreover, at the end of the last trading period, the closing price was at $128.68.
For Armstrong World Industries Inc (NYSE:AWI), B of A Securities downgraded the previous rating of Buy to the current rating Neutral. The stock has a 52-week-high of 111.46 and a 52-week-low of 61.56. At the end of the last trading period, Armstrong World Indus closed at $62.91.
According to Stifel, the prior rating for New Fortress Energy Inc (NASDAQ:NFE) was changed from Buy to Hold. New Fortress Energy earned $0.24 in the second quarter, compared to $0.28 in the year-ago quarter. At the moment, the stock has a 52-week-high of 54.92 and a 52-week-low of 7.01. New Fortress Energy closed at $49.16 at the end of the last trading period.
According to Morgan Stanley, the prior rating for Harley-Davidson Inc (NYSE:HOG) was changed from Overweight to Equal-Weight. The stock has a 52-week-high of 40.86 and a 52-week-low of 14.31. At the end of the last trading period, Harley-Davidson closed at $35.37.
Evercore ISI Group downgraded the previous rating for Frontline Ltd (NYSE:FRO) from In-Line to Underperform. Frontline earned $1.04 in the second quarter, compared to $0.02 in the year-ago quarter. At the moment, the stock has a 52-week-high of 13.33 and a 52-week-low of 5.98. Frontline closed at $6.04 at the end of the last trading period.
According to JP Morgan, the prior rating for FB Financial Corp (NYSE:FBK) was changed from Neutral to Underweight. In the third quarter, FB Financial earned $1.46. At the moment, the stock has a 52-week-high of 40.33 and a 52-week-low of 14.38. FB Financial closed at $28.65 at the end of the last trading period.
Barclays downgraded the previous rating for Diamondback Energy Inc (NASDAQ:FANG) from Overweight to Equal-Weight. Diamondback Energy earned $0.15 in the second quarter, compared to $2.11 in the year-ago quarter. The stock has a 52-week-high of 96.92 and a 52-week-low of 14.55. At the end of the last trading period, Diamondback Energy closed at $26.57.
For DTE Energy Co (NYSE:DTE), BMO Capital downgraded the previous rating of Outperform to the current rating Market Perform. In the third quarter, DTE Energy showed an EPS of $2.61, compared to $1.91 from the year-ago quarter. At the moment, the stock has a 52-week-high of 135.67 and a 52-week-low of 71.21. DTE Energy closed at $127.25 at the end of the last trading period.
According to Credit Suisse, the prior rating for Veoneer Inc (NYSE:VNE) was changed from Neutral to Underperform. In the third quarter, Veoneer showed an EPS of $0.96, compared to $1.20 from the year-ago quarter. The stock has a 52-week-high of 18.9 and a 52-week-low of 5.25. At the end of the last trading period, Veoneer closed at $15.83.
For Varian Medical Systems Inc (NYSE:VAR), Baird downgraded the previous rating of Outperform to the current rating Neutral. For the fourth quarter, Varian Medical Systems had an EPS of $1.12, compared to year-ago quarter EPS of $1.21. The stock has a 52-week-high of 176.19 and a 52-week-low of 89.62. At the end of the last trading period, Varian Medical Systems closed at $173.02.
According to Piper Sandler, the prior rating for Livongo Health Inc (NASDAQ:LVGO) was changed from Overweight to Neutral. For the third quarter, Livongo Health had an EPS of No EPS Value , compared to year-ago quarter EPS of $0.05. At the moment, the stock has a 52-week-high of 151.049 and a 52-week-low of 18.76. Livongo Health closed at $142.89 at the end of the last trading period.

根据克雷格-哈勒姆(Craig-Hallum)的说法，之前的评级为恩相能源公司(纳斯达克：ENPH)已从买入更改为持有。第三季度，恩相能源公司的每股收益为0.30美元，而去年同期为0.30美元。该股的52周高点为118.939，52周低点为17.18.上一交易期尾盘，恩相能源收报98.63美元。
为恩相能源公司(纳斯达克：ENPH)，HC Wainwright&Co.将之前对买入的评级下调至当前评级中性。第三季度，恩相能源公司的每股收益为0.30美元，而去年同期为0.30美元。恩相能源目前的股票表现显示，52周高点为118.939，52周低点为17.18.而且，在上个交易期结束时，收盘价为98.63美元。
根据高盛(Goldman Sachs)的说法，之前的评级为Relmada治疗公司(纳斯达克：RLMD)从买入改为中性。目前，该股的52周高点为54.0，52周低点为21.85。Relmada Treeutics上一交易期尾盘报33.06美元。
为精密科学公司(纳斯达克：EXAS)，花旗将之前对买入的评级下调至当前评级中性。第三季度，Exact Sciences显示每股收益为0.07美元，而去年同期为0.31美元。精密科学目前的股票表现显示，52周高点为141.9，52周低点为35.2512。而且，在上个交易期结束时，收盘价为131.12美元。
为Everbridge Inc.(纳斯达克：EVBG)，B of A Securities将之前的买入评级下调至当前评级中性。第二季度，Everbridge的每股收益为0.06美元，而去年同期为0.07美元。目前长桥的股票表现显示，52周高点为165.79，52周低点为66.19.而且，在上个交易期结束时，收盘价为128.68美元。
为阿姆斯特朗世界工业公司纽约证券交易所代码：AWI)，B of A Securities将之前的买入评级下调至当前评级中性。该股的52周高点为111.46，52周低点为61.56.阿姆斯特朗世界印度河股票上一交易期尾盘报62.91美元。
根据Stifel的说法，之前的评级为新堡垒能源公司(纳斯达克：NFE)已从买入更改为持有。新堡垒能源公司第二季度盈利0.24美元，而去年同期为0.28美元。目前，该股的52周高点为54.92，52周低点为7.01。新堡垒能源上交易期尾盘收报49.16美元。
据摩根士丹利(Morgan Stanley)称，之前的评级为哈雷-戴维森公司纽约证券交易所代码：小猪)从超重改为等重。该股的52周高点为40.86，52周低点为14.31。上一交易期尾盘，哈雷戴维森收报35.37美元。
Evercore ISI Group下调之前的评级为前线有限公司纽约证券交易所代码：从前)从In-Line(在线)到UnderPerformance(未完成)。Frontline第二季度的利润为1.04美元，而去年同期为0.02美元。目前，该股的52周高点为13.33，52周低点为5.98。前线上一交易期尾盘报6.04美元。
根据摩根大通(JP Morgan)的说法，之前的评级为FB金融公司纽约证券交易所代码：FBK)由中性改为减重。第三季度，FB Financial的利润为1.46美元。目前，该股的52周高点为40.33，52周低点为14.38。FB Financial上交易日尾盘报28.65美元。
巴克莱下调之前的评级为响尾蛇能源公司(纳斯达克：方从超重到等重。响尾蛇能源第二季度盈利0.15美元，而去年同期为2.11美元。该股的52周高点为96.92，52周低点为14.55。上一交易期尾盘，响尾蛇能源收报26.57美元。
为DTE能源公司纽约证券交易所代码：DTE)，BMO Capital将之前评级为表现优于大盘下调至当前评级市场表现。第三季度，DTE Energy显示每股收益为2.61美元，而去年同期为1.91美元。目前该股的52周高点为135.67，52周低点为71.21.东兴能源上交易期尾盘收报127.25美元。
根据瑞士信贷(Credit Suisse)的说法，之前的评级为Veoneer Inc.纽约证券交易所代码：VNE)已从中性更改为表现不佳。第三季度，Veoneer显示每股收益为0.96美元，而去年同期为1.20美元。该股的52周高点为18.9，52周低点为5.25。上个交易期尾盘，Veoneer收报15.83美元。
为瓦里安医疗系统公司纽约证券交易所代码：变量)，Baird将之前的评级下调至跑赢大盘，至当前评级中性。第四季度，瓦里安医疗系统公司的每股收益为1.12美元，而去年同期为1.21美元。该股的52周高点为176.19，52周低点为89.62.上个交易期尾盘，瓦里安医疗系统公司收报173.02美元。
根据派珀·桑德勒(Piper Sandler)的说法，之前的评级为Livongo Health Inc.(纳斯达克：LVGO)由增持改为中性。第三季度，Livongo Health的每股收益为无EPS值，而去年同期每股收益为0.05美元。目前，该股的52周高点为151.049，52周低点为18.76.Livongo Health上一交易期尾盘报142.89美元。

Initiations

启蒙行动

UBS initiated coverage on Vertex Pharmaceuticals Inc (NASDAQ:VRTX) with a Buy rating. The price target for Vertex Pharmaceuticals is set to $287.00. Vertex Pharmaceuticals earned $2.61 in the second quarter, compared to $1.26 in the year-ago quarter. At the moment, the stock has a 52-week-high of 306.08 and a 52-week-low of 192.32. Vertex Pharmaceuticals closed at $212.19 at the end of the last trading period.
With a current rating of Buy, Berenberg initiated coverage on Terreno Realty Corp (NYSE:TRNO). The price target seems to have been set at $70.00 for Terreno Realty. Terreno Realty earned $0.19 in the second quarter, compared to $0.33 in the year-ago quarter. At the moment, the stock has a 52-week-high of 64.24 and a 52-week-low of 42.115. Terreno Realty closed at $58.25 at the end of the last trading period.
UBS initiated coverage on Sarepta Therapeutics Inc (NASDAQ:SRPT) with a Buy rating. The price target for Sarepta Therapeutics is set to $212.00. For the second quarter, Sarepta Therapeutics had an EPS of $1.51, compared to year-ago quarter EPS of $0.83. At the moment, the stock has a 52-week-high of 175.0 and a 52-week-low of 78.06. Sarepta Therapeutics closed at $139.62 at the end of the last trading period.
Berenberg initiated coverage on Rexford Industrial Realty Inc (NYSE:REXR) with a Buy rating. The price target for Rexford Industrial Realty is set to $56.00. For the third quarter, Rexford Industrial Realty had an EPS of $0.33, compared to year-ago quarter EPS of $0.31. At the moment, the stock has a 52-week-high of 53.48 and a 52-week-low of 31.7871. Rexford Industrial Realty closed at $47.69 at the end of the last trading period.
With a current rating of Buy, Berenberg initiated coverage on Plymouth Industrial REIT Inc (NYSE:PLYM). The price target seems to have been set at $15.00 for Plymouth Industrial REIT. Plymouth Industrial REIT earned $0.45 in the second quarter, compared to $0.43 in the year-ago quarter. At the moment, the stock has a 52-week-high of 21.4964 and a 52-week-low of 7.79. Plymouth Industrial REIT closed at $12.75 at the end of the last trading period.
UBS initiated coverage on PTC Therapeutics Inc (NASDAQ:PTCT) with a Neutral rating. The price target for PTC Therapeutics is set to $55.00. PTC Therapeutics earned $2.62 in the second quarter, compared to $0.75 in the year-ago quarter. The current stock performance of PTC Therapeutics shows a 52-week-high of 59.89 and a 52-week-low of 30.7923. Moreover, at the end of the last trading period, the closing price was at $53.26.
Berenberg initiated coverage on Monmouth Real Estate Investment Corp (NYSE:MNR) with a Buy rating. The price target for Monmouth Real Estate Inv is set to $17.00. For the third quarter, Monmouth Real Estate Inv had an EPS of $0.20, compared to year-ago quarter EPS of $0.21. The stock has a 52-week-high of 15.53 and a 52-week-low of 8.42. At the end of the last trading period, Monmouth Real Estate Inv closed at $14.22.
With a current rating of Buy, UBS initiated coverage on Immunovant Inc (NASDAQ:IMVT). The price target seems to have been set at $61.00 for Immunovant. Immunovant earned $0.38 in the first quarter. The current stock performance of Immunovant shows a 52-week-high of 43.9399 and a 52-week-low of 8.34. Moreover, at the end of the last trading period, the closing price was at $42.93.
With a current rating of Neutral, UBS initiated coverage on Gilead Sciences Inc (NASDAQ:GILD). The price target seems to have been set at $61.00 for Gilead Sciences. Gilead Sciences earned No EPS Value in the third quarter, compared to $1.75 in the year-ago quarter. The current stock performance of Gilead Sciences shows a 52-week-high of 85.97 and a 52-week-low of 59.395. Moreover, at the end of the last trading period, the closing price was at $60.01.
With a current rating of Buy, B of A Securities initiated coverage on Cal-Maine Foods Inc (NASDAQ:CALM). The price target seems to have been set at $47.00 for Cal-Maine Foods. In the first quarter, Cal-Maine Foods showed an EPS of $0.40, compared to $0.94 from the year-ago quarter. At the moment, the stock has a 52-week-high of 46.6576 and a 52-week-low of 30.74. Cal-Maine Foods closed at $38.87 at the end of the last trading period.
With a current rating of Neutral, UBS initiated coverage on Biogen Inc (NASDAQ:BIIB). The price target seems to have been set at $268.00 for Biogen. Biogen earned $8.84 in the third quarter, compared to $9.17 in the year-ago quarter. The current stock performance of Biogen shows a 52-week-high of 374.99 and a 52-week-low of 254.925. Moreover, at the end of the last trading period, the closing price was at $255.30.
With a current rating of Neutral, UBS initiated coverage on Amgen Inc (NASDAQ:AMGN). The price target seems to have been set at $232.00 for Amgen. Amgen earned No EPS Value in the third quarter, compared to $3.66 in the year-ago quarter. The stock has a 52-week-high of 264.97 and a 52-week-low of 177.05. At the end of the last trading period, Amgen closed at $223.46.
With a current rating of Neutral, UBS initiated coverage on Alexion Pharmaceuticals Inc (NASDAQ:ALXN). The price target seems to have been set at $133.00 for Alexion Pharmaceuticals. In the second quarter, Alexion Pharmaceuticals showed an EPS of $3.11, compared to $2.64 from the year-ago quarter. The current stock performance of Alexion Pharmaceuticals shows a 52-week-high of 128.57 and a 52-week-low of 72.67. Moreover, at the end of the last trading period, the closing price was at $120.00.
With a current rating of Neutral, JP Morgan initiated coverage on Hyliion Holdings Corp (NYSE:HYLN). The price target seems to have been set at $27.00 for Hyliion Holdings. The stock has a 52-week-high of 44.9 and a 52-week-low of 20.4. At the end of the last trading period, Hyliion Holdings closed at $21.31.
Jefferies initiated coverage on Burlington Stores Inc (NYSE:BURL) with a Buy rating. The price target for Burlington Stores is set to $255.00. In the second quarter, Burlington Stores showed an EPS of $0.56, compared to $1.36 from the year-ago quarter. The stock has a 52-week-high of 250.89 and a 52-week-low of 105.67. At the end of the last trading period, Burlington Stores closed at $200.18.

瑞银在Vertex制药公司(纳斯达克：VRTX)，评级为买入。Vertex PharmPharmticals的目标价定为287.00美元。Vertex制药公司第二季度的利润为2.61美元，而去年同期为1.26美元。目前，该股的52周高点为306.08，52周低点为192.32。Vertex PharmPharmticals上一交易期尾盘报212.19美元。
目前评级为买入，贝伦伯格在特雷诺房地产公司纽约证券交易所代码：TRNO)。Terreno Realty的目标价似乎被设定在70.00美元。Terreno Realty第二季度盈利0.19美元，而去年同期为0.33美元。目前，该股的52周高点为64.24点，52周低点为42.115点。Terreno Realty上一交易期尾盘报58.25美元。
瑞银在Sarepta治疗公司(纳斯达克：SRPT)，评级为买入。萨雷普塔治疗公司的目标价格定为212.00美元。第二季度，Sarepta治疗公司的每股收益为1.51美元，而去年同期为0.83美元。目前该股的52周高点为175.0，52周低点为78.06.赛瑞普塔治疗公司上一交易期尾盘收报139.62美元。
贝伦伯格发起了关于雷克斯福德工业地产公司纽约证券交易所代码：REXR)，评级为买入。雷克斯福德工业地产(Rexford Industrial Realty)的目标价定为56.00美元。第三季度，雷克斯福德工业地产(Rexford Industrial Realty)的每股收益为0.33美元，而去年同期为0.31美元。目前，该股的52周高点为53.48点，52周低点为31.7871点。Rexford Industrial Realty上一交易期尾盘报47.69美元。
目前评级为买入，贝伦伯格在普利茅斯工业房地产投资信托基金公司纽约证券交易所代码：折叠机)。普利茅斯工业房地产投资信托基金的目标价似乎被设定在15.00美元。普利茅斯工业房地产投资信托基金第二季度盈利0.45美元，而去年同期为0.43美元。目前该股的52周高点为21.4964，52周低点为7.79.普利茅斯工业房地产投资信托基金上一交易期尾盘报12.75美元。
瑞银在PTC治疗公司(纳斯达克：PTCT)，评级为中性。PTC治疗公司的目标价定为55.00美元。PTC治疗公司第二季度的利润为2.62美元，而去年同期为0.75美元。PTC治疗公司目前的股票表现显示，52周高点为59.89点，52周低点为30.7923点。而且，在上个交易期结束时，收盘价为53.26美元。
贝伦伯格发起了关于蒙茅斯房地产投资公司纽约证券交易所代码：Mnr)，评级为买入。蒙茅斯房地产Inv的目标价定为17.00美元。第三季度，蒙茅斯房地产公司的每股收益为0.20美元，而去年同期为0.21美元。该股的52周高点为15.53，52周低点为8.42。上交易期尾盘，蒙茅斯地产Inv收报14.22美元。
在目前评级为买入的情况下，瑞银在Immunovant Inc.(纳斯达克：IMVT)。Immunovant的目标价格似乎被设定在61.00美元。Immunovant第一季度盈利0.38美元。目前Immunovant的股票表现显示，52周高点为43.9399，52周低点为8.34.而且，在上个交易期结束时，收盘价为42.93美元。
在目前评级为中性的情况下，瑞银在吉利德科学公司(纳斯达克：镀金)。吉利德科学公司的目标价似乎被设定在61.00美元。吉利德科学公司赢得了无EPS值第三季度为1.75美元，而去年同期为1.75美元。吉利德科学目前的股票表现显示，52周高点为85.97%，52周低点为59.395。而且，在上个交易期结束时，收盘价为60.01美元。
在目前评级为买入的情况下，美国银行证券在加州缅因州食品公司(Cal-Maine Foods Inc.)(纳斯达克：平静)。Cal-Maine Foods的目标价似乎被设定在47.00美元。第一季度，Cal-Maine Foods的每股收益为0.40美元，而去年同期为0.94美元。目前该股的52周高点为46.6576，52周低点为30.74.Cal-Maine Foods上一交易期尾盘报38.87美元。
在目前评级为中性的情况下，瑞银在生物遗传公司(纳斯达克：BIIB)。生物遗传公司的目标价格似乎被设定在268.00美元。Biogen第三季度盈利8.84美元，而去年同期为9.17美元。生物遗传目前的股票表现显示，52周高点为374.99，52周低点为254.925。而且，在上个交易期结束时，收盘价为255.30美元。
在目前评级为中性的情况下，瑞银在安进公司(纳斯达克：AMGN)。安进的目标价似乎被设定在232.00美元。安进赢得无EPS值第三季度为3.66美元，而去年同期为3.66美元。该股的52周高点为264.97，52周低点为177.05。上一交易期尾盘，安进收报223.46美元。
在目前评级为中性的情况下，瑞银在Alexion制药公司(纳斯达克：ALXN)。亚历克森制药公司的目标价似乎被设定在133.00美元。第二季度，Alexion制药公司的每股收益为3.11美元，而去年同期为2.64美元。Alexion PharmPharmticals目前的股票表现显示，52周高点为128.57，52周低点为72.67.而且，在上个交易期结束时，收盘价为120.00美元。
目前评级为中性，摩根大通在海利安控股公司纽约证券交易所代码：HYLN)。Hyliion Holdings的目标价似乎被设定在27.00美元。该股的52周高点为44.9，52周低点为20.4。上一交易期尾盘，Hyliion Holdings收报21.31美元。
Jefferies发起了关于伯灵顿百货公司纽约证券交易所代码：伯尔)，评级为买入。伯灵顿百货的目标价定为255.00美元。第二季度，Burlington Stores的每股收益为0.56美元，而去年同期为1.36美元。该股的52周高点为250.89，52周低点为105.67。上一交易期尾盘，Burlington Stores收报200.18美元。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

Benzinga's Top Upgrades, Downgrades For October 28, 2020

Benzinga's Top Upgrades, Downgrades For October 28, 2020

Upgrades

Downgrades

Initiations

Upgrades

升级

Downgrades

降级

Initiations

启蒙行动

风险及免责提示

声明